SCM
PRAH

Stevens Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Stevens Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,511
Closed -$507K – 938
2018
Q4 		$507K Buy
+5,511
New +$558K 0.03% 492
2017
Q4 		– Sell
-23,506
Closed -$1.79M – 1105
2017
Q3 		$1.79M Buy
+23,506
New +$1.78M 0.07% 333

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Stevens Capital Management's PRAH Position: Q1 2019 in Review

Stevens Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 5,511 shares — an estimated $507K sold.

Stevens Capital Management first reported a position in PRAH in Q3 2017 and held it in 2 quarters. The position peaked at $1.79M in Q3 2017. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • Stevens Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • Stevens Capital Management sold 5,511 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $507K.
  • Stevens Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 2 quarters.
  • Stevens Capital Management's PRA Health Sciences, Inc. position peaked at $1.79M in Q3 2017.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Stevens Capital Management's 13F filing for Q1 2019, filed 3 May 2019.